Sonic Healthcare Ltd
SHL: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| Kw | LOCK|x#%& | LOCK|db$<@t |
Sonic Healthcare Earnings: Solid Industry Outperformance and Margins Poised to Expand
Sonic's interim 2026 EBITDA rose 10% on 5% organic sales growth and underlying EBITDA margins up 30 basis points to 18%. Full-year EBITDA guidance of 8% growth at the midpoint in constant-currency was reaffirmed, and guided depreciation and interest expense was modestly lowered. Shares rallied 10%.
